Intermediate Filament Proteostasis and RNA regulation in Giant Axonal Neuropathy
巨轴突神经病中的中间丝蛋白稳态和 RNA 调节
基本信息
- 批准号:10195588
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAffectAmyotrophic Lateral SclerosisAxonAxonal NeuropathyBindingBiologicalBiologyCRISPR/Cas technologyCaliberChildhoodChronicComputer AnalysisCytoskeletonDataDefectDiseaseDisease ProgressionElectron MicroscopyFeasibility StudiesFunctional disorderGap JunctionsGenesGenetic TranslationGiant CellsHumanImage AnalysisImpairmentIn VitroIntermediate Filament ProteinsIntermediate FilamentsLeadLinkMeasuresMessenger RNAMicrofluidic MicrochipsMicrofluidicsMolecularMorphologyMotor NeuronsMutationNeurodegenerative DisordersNeuronsObservational StudyPathogenesisPathologicPathologyPatientsPatternPeripheral NervesPharmacologyProteinsQuality ControlRNARNA TransportRNA metabolismRNA-Binding ProteinsRegulationStructural ProteinStructureSwellingSystemTestingTherapeuticTimeTranslatingTranslationsUntranslated RNAWorkcell component structuredesignfrontotemporal lobar dementia-amyotrophic lateral sclerosisgiant axonal neuropathygigaxoninin vivoinduced pluripotent stem cellinhibitor/antagonistinsightloss of function mutationneurofilamentneuronal cell bodynovelprotein TDP-43proteostasisquantitative imagingscaffoldstress granuletooltranscriptomicsubiquitin-protein ligase
项目摘要
ABSTRACT
Intermediate filaments (IFs) are critical structural components of the cell cytoskeleton. Neurofilaments (NFs), the
principal IFs of neurons, regulate axon size and caliber and are dysregulated in many neurodegenerative
diseases. Abnormal NF inclusions within ‘giant’ axon swellings are hallmark features of the rare and fatal disease
Giant Axonal Neuropathy (GAN), which is caused by mutations in the gene KLHL16. The origin and function of
NF inclusions in GAN are poorly understood. We have made the first observation that TDP-43, an essential
RNA-binding protein, co-localizes with NFs within large axonal inclusions of human GAN induced pluripotent
stem cell-derived motor neurons (iPSC-MNs). These findings reveal shared mechanisms between GAN and
other TDP-43 proteinopathies, most notably amyotrophic lateral sclerosis (ALS). The objective in this application
is to examine if GAN neurons are affected by abnormal RNA metabolism. The following observations and
feasibility studies form the basis of the proposal: (i) “dense granular bodies” that resemble RNA stress granules
are prominent features of IF inclusions in GAN patient neurons in vivo; (ii) The human KLHL16 mRNA associates
with TDP-43 and accumulates in stress granules; (iii) The novel, patient-derived iPSC-MN microfluidic system
we developed mirrors the axonal IF pathology of GAN and is amenable to rigorous quantitative image analysis
of the inclusions; (iv) Axonal inclusions in GAN iPSC-MNs contain TDP-43, and they can be pharmacologically
disrupted. The two main questions we aim to address here, are: 1. Do the axonal NF/TDP-43 inclusions
sequester other stress granule components and KLHL16 mRNA (Aim1), and 2. Is the presence of axonal
NF/TDP-43 inclusions associated with altered global and KLHL16-specific mRNA translation in GAN neurons?
(Aim2). We anticipate that answers to these basic questions will ultimately lead us to the origin of IF inclusions
in giant GAN axons and to the functional consequences of this striking pathology in GAN disease progression.
抽象的
中间细丝(IFS)是细胞细胞骨架的关键构件。
神经元的主要IF,调节轴突的大小和口径在许多神经退行性中失调
疾病。
巨大的轴突神经病(GAN),是由基因KLH16中的突变引起的。
我们首先观察到TDP-43,这是必不可少的。
RNA结合蛋白,与NFS在人类GAN诱导多能的大轴突夹杂物中共定位
干细胞衍生的运动神经元(IPSC-MN)。
其他TDP-43蛋白质病,最著名的肌萎缩性外侧扇形(ALS)。
是检查GAN神经元是否受到异常RNA代谢的影响。
盛宴构成了提案的基础:(i)类似于RNA应力颗粒的“密集颗粒体”
是体内GAN患者神经元中的夹杂物的突出特征;
TDP-43并积聚在应力颗粒中;
如果GAN的病理和严格的定量图像分析,我们开发了轴突
夹杂物;
我们要在这里解决的两个主要问题是:1。轴突NF/TDP-43
隔离其他应力颗粒成分和KLHL16 mRNA(AIM1),而2。
NF/TDP-43夹杂物与GAN神经元中的全局和KLHL16特异性mRNA翻译有关?
(AIM2)。
在GAN疾病进展中这种惊人的病理学的巨型GAN轴突和功能性调节中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diane Armao其他文献
Diane Armao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diane Armao', 18)}}的其他基金
Intermediate Filament Proteostasis and RNA regulation in Giant Axonal Neuropathy
巨轴突神经病中的中间丝蛋白稳态和 RNA 调节
- 批准号:
10415093 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:
相似海外基金
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
- 批准号:
10678195 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别: